USPTO serial 79449477
Reviewed by CopyMark Law Group
The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Application software; embedded operating software; computer hardware and software; computer software for data and document capture, transmission, storage and indexing; computer software platforms; Software as a Medical Device (SaMD). | ACTIVE | — |
| 042 | Computer software development; Platform as a Service (PaaS); Software as a Service (SaaS); design and development of computer hardware and software for medical use; research in the field of artificial intelligence; biomedical research; medical research; scientific research for medical purposes; providing information and data with respect to scientific and technological research and development; scientific and technological services as well as research and development services relating thereto; industrial analysis and industrial research services; data migration services; providing information and data with respect to medical and veterinary research and development. | ACTIVE | — |
| 044 | Remote monitoring of medical data for medical diagnosis and treatment purposes; medical advice; medical examinations; medical information; medical testing services relating to disease diagnosis and treatment; medical information services provided via the Internet; medical testing for the diagnosis and treatment of persons; medical diagnostic services (testing and analysis); provision of medical information; medical services in the field of ophthalmology, including eye diseases and oculomics (namely autoimmune diseases (Graves’ disease, multiple sclerosis (MS)), chronic kidney disease, vascular diseases (diabetes, heart disease, high risk of stroke, and hypertension), hereditary diseases (Stargardt disease and retinitis pigmentosa), and neurodegenerative diseases (Alzheimer’s disease and Parkinson’s disease)), particularly vision assessment. treatment of vision disorders; professional consultancy in the field of medical technology, medical surgery and orthopedics. | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 10, 2026 | RFNT | REFUSAL PROCESSED BY IB | — |
| Aug 25, 2026 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Aug 25, 2026 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jun 18, 2026 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jun 17, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 15, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| May 8, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| May 8, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 7, 2026 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |